Reply to 'Risk of malignancies associated with ustekinumab'.
作者信息
Nardone B, West D P
机构信息
Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, U.S.A.
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, U.S.A.
出版信息
Br J Dermatol. 2018 Jan;178(1):296-297. doi: 10.1111/bjd.16007. Epub 2017 Nov 29.
PMID:28940400
Abstract
摘要
相似文献
1
Reply to 'Risk of malignancies associated with ustekinumab'.
Br J Dermatol. 2018 Jan;178(1):296-297. doi: 10.1111/bjd.16007. Epub 2017 Nov 29.
2
Risk of malignancies associated with ustekinumab.
Br J Dermatol. 2018 Jan;178(1):299-300. doi: 10.1111/bjd.16002. Epub 2017 Dec 1.
3
Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database.
Br J Dermatol. 2017 Nov;177(5):e220-e221. doi: 10.1111/bjd.15752. Epub 2017 Oct 22.
4
The brave new world of biosimilars ('similar biologics') in India.
Postgrad Med J. 2017 Oct;93(1104):577-579. doi: 10.1136/postgradmedj-2017-134806. Epub 2017 May 25.
5
Pharmacovigilance activities in the United States, European Union and Japan: harmonic convergence or convergent evolution?
Food Drug Law J. 2008;63(3):683-700.
6
[Registration of clinical trials and other study protocols].
Med Clin (Barc). 2013 Nov 2;141(9):414-5. doi: 10.1016/j.medcli.2013.02.009. Epub 2013 Apr 6.
7
International Conference on Harmonisation; guidance on E2E Pharmacovigilance Planning; availability. Notice.
Fed Regist. 2005 Apr 1;70(62):16827-8.
8
The US Food and Drug Administration-European Medicines Agency collaboration in pharmacovigilance: common objectives and common challenges.
Drug Saf. 2015 Jan;38(1):13-5. doi: 10.1007/s40264-014-0259-3.
9
Pharmacovigilance in Europe: Place of the Pharmacovigilance Risk Assessment Committee (PRAC) in organisation and decisional processes.
Therapie. 2016 Apr;71(2):161-9. doi: 10.1016/j.therap.2016.02.008. Epub 2016 Mar 8.
10
Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works.
Drug Saf. 2017 Oct;40(10):855-869. doi: 10.1007/s40264-017-0572-8.
引用本文的文献
1
Inhibition of interleukin-12 and/or interleukin-23 for the treatment of psoriasis: What is the evidence for an effect on malignancy?
Exp Dermatol. 2018 Jul;27(7):737-747. doi: 10.1111/exd.13676.
Zotero 插件